Clotrimazole (2% w/w) is a topical antifungal preparation widely used in dermatology to treat superficial fungal infections of the skin. It belongs to the imidazole class of antifungal agents and works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. This disruption weakens the membrane structure, leading to leakage of cellular contents and ultimately the death of the fungus. Clinically, Clotrimazole 2% is applied for conditions such as **tinea infections** (including athlete’s foot, jock itch, and ringworm), **cutaneous candidiasis**, and **pityriasis versicolor**, a superficial yeast infection that causes discolored patches on the skin. Its broad spectrum of activity against dermatophytes, yeasts, and some molds makes it a versatile option in managing common fungal skin disorders. The cream formulation allows for direct application to affected areas, ensuring localized action and effective penetration into the skin layers. In addition to its therapeutic role, Clotrimazole contributes to improved patient comfort by alleviating symptoms such as itching, redness, and scaling associated with fungal infections. Its use in dermatological practice underscores the importance of topical antifungals in providing targeted treatment while minimizing systemic exposure. Overall, Clotrimazole (2% w/w) remains a cornerstone in the management of superficial fungal infections, combining efficacy, safety, and ease of use in a formulation that supports both clinical outcomes and patient adherence.